Goldenwell Biotech Stock Performance
| GWLL Stock | USD 1.05 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of -1.14, which attests to a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Goldenwell Biotech are expected to decrease slowly. On the other hand, during market turmoil, Goldenwell Biotech is expected to outperform it slightly. At this point, Goldenwell Biotech has a negative expected return of -0.77%. Please make sure to check out Goldenwell Biotech's standard deviation, value at risk, as well as the relationship between the Value At Risk and day typical price , to decide if Goldenwell Biotech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Goldenwell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
| Quick Ratio | 1.30 | |
| Fifty Two Week Low | 0.2950 | |
| Fifty Two Week High | 0.2950 |
Goldenwell |
Goldenwell Biotech Relative Risk vs. Return Landscape
If you would invest 201.00 in Goldenwell Biotech on November 14, 2025 and sell it today you would lose (96.00) from holding Goldenwell Biotech or give up 47.76% of portfolio value over 90 days. Goldenwell Biotech is currently does not generate positive expected returns and assumes 8.062% risk (volatility on return distribution) over the 90 days horizon. In different words, 72% of pink sheets are less volatile than Goldenwell, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Goldenwell Biotech Target Price Odds to finish over Current Price
The tendency of Goldenwell Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.05 | 90 days | 1.05 | roughly 97.0 |
Based on a normal probability distribution, the odds of Goldenwell Biotech to move above the current price in 90 days from now is roughly 97.0 (This Goldenwell Biotech probability density function shows the probability of Goldenwell Pink Sheet to fall within a particular range of prices over 90 days) .
Goldenwell Biotech Price Density |
| Price |
Predictive Modules for Goldenwell Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Goldenwell Biotech. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Goldenwell Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Goldenwell Biotech is not an exception. The market had few large corrections towards the Goldenwell Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Goldenwell Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Goldenwell Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.61 | |
β | Beta against Dow Jones | -1.14 | |
σ | Overall volatility | 0.73 | |
Ir | Information ratio | -0.1 |
Goldenwell Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Goldenwell Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Goldenwell Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Goldenwell Biotech generated a negative expected return over the last 90 days | |
| Goldenwell Biotech has high historical volatility and very poor performance | |
| Goldenwell Biotech has some characteristics of a very speculative penny stock | |
| Goldenwell Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 18.97 K. Net Loss for the year was (107.48 K) with profit before overhead, payroll, taxes, and interest of 8.39 K. | |
| Goldenwell Biotech currently holds about 42.86 K in cash with (202.57 K) of positive cash flow from operations. | |
| Roughly 63.0% of the company shares are held by company insiders |
Goldenwell Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Goldenwell Pink Sheet often depends not only on the future outlook of the current and potential Goldenwell Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Goldenwell Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Float Shares | 36M | |
| Average Daily Volume In Three Month | 750 |
Goldenwell Biotech Fundamentals Growth
Goldenwell Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Goldenwell Biotech, and Goldenwell Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Goldenwell Pink Sheet performance.
| Return On Equity | -36.4 | |||
| Return On Asset | -17.19 | |||
| Operating Margin | (568.00) % | |||
| Current Valuation | 28.31 M | |||
| Shares Outstanding | 96 M | |||
| Price To Book | 98.33 X | |||
| Revenue | 18.97 K | |||
| Cash And Equivalents | 42.86 K | |||
| Total Debt | 32.87 K | |||
| Debt To Equity | 0.14 % | |||
| Cash Flow From Operations | (202.57 K) | |||
About Goldenwell Biotech Performance
By examining Goldenwell Biotech's fundamental ratios, stakeholders can obtain critical insights into Goldenwell Biotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Goldenwell Biotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company was incorporated in 2019 and is based in Twinsburg, Ohio. Goldenwell Biotech is traded on OTC Exchange in the United States.Things to note about Goldenwell Biotech performance evaluation
Checking the ongoing alerts about Goldenwell Biotech for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Goldenwell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Goldenwell Biotech generated a negative expected return over the last 90 days | |
| Goldenwell Biotech has high historical volatility and very poor performance | |
| Goldenwell Biotech has some characteristics of a very speculative penny stock | |
| Goldenwell Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 18.97 K. Net Loss for the year was (107.48 K) with profit before overhead, payroll, taxes, and interest of 8.39 K. | |
| Goldenwell Biotech currently holds about 42.86 K in cash with (202.57 K) of positive cash flow from operations. | |
| Roughly 63.0% of the company shares are held by company insiders |
- Analyzing Goldenwell Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Goldenwell Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Goldenwell Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Goldenwell Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Goldenwell Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Goldenwell Biotech's pink sheet. These opinions can provide insight into Goldenwell Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.